The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8592-8601

  Njenga, M Kariuki ^a   Asakura, Kunihiko ^a   Hunter, Samuel F ^a   Wettstein, Peter ^a   Pease, Larry R ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; GLIA; GRAY MATTER; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL; VIROGENESIS; VIRUS REPLICATION; WHITE MATTER;

EID: 0030864080     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8592-8601.1997     Document Type: Article

References (54)

1. Asakura, K., D. J. Miller, K. Murray, R. Bansal, S. E. Pfeiffer, and M. Rodriguez. 1996. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J. Neurosci. Res. 43:273-281.
2. Aubert, C., and M. Brahic. 1995. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus. J. Virol. 69:3197-3200.
3. Aubert, C., M. Chamorro, and M. Brahic. 1987. Identification of Theiler's virus infected cells in the central nervous system of mouse during demyelinating disease. Microb. Pathog. 3:319-326.
4. Borrow, P., P. Tonks, C. R. Welsh, and A. A. Nash. 1992. The role of CD8+ T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 1992:1861-1865.
5. Brahic, M., W. G. Stroop, and J. R. Baringer. 1981. Theiler's virus persists in glial cells during demyelinating disease. Cell 26:123-128.
6. Bureau, J.-F., X. Montagutelli, F. Bihl, S. Lefebvre, J.-L. Guénet, and M. Brahic. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91.
7. Cash, E., M. Chamorro, and M. Brahic. 1985. Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice. Virology 144:290-294.
8. Cash, E., M. Chamorro, and M. Brahic. 1986. Quantitation, with a new assay, of Theiler's virus capsid protein in the central nervous system of mice. J. Virol. 60:558-563.
9. Ceredig, R., J. W. Lowenthal, M. Nabholz, and H. R. MacDonald. 1985. Expression of interleukin-2 receptor as a differentiation marker on intrathymic stem cells. Nature 314:98-100.
10. Clatch, R. J., R. W. Melvold, S. D. Miller, and H. L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408-1414.
11. Clatch, R. J., S. D. Miller, R. Metzner, M. C. Dal Canto, and H. L. Lipton. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176:244-254.
12. Dal Canto, M. C., and H. L. Lipton. 1975. Primary demyelination in Theiler's virus infection: an ultrastructural study. Lab. Invest. 33:626-637.
13. Dal Canto, M. C., and H. L. Lipton. 1982. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106:20-29.
14. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch. 1983. Characterization of murine antigenic determinant, designated L3T4a recognized by monoclonal antibody GK 1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen reactivity. Immunol. Rev. 74:29-56.
15. 2-microglobulin-deficient mice. J. Virol. 67:589-592.
16. Fiette, L., M. Brahic, and C. Rossi-Penna. 1996. Infection of class II-deficient mice by DA strain of Theiler's virus. J. Virol. 70:4811-4815.
17. Fu, J., M. Rodriguez, and R. P. Roos. 1990. Strains from both Theiler's virus subgroups encode a determinant for demyelination. J. Virol. 64:6345-6348.
18. Graves, M. C., L. Bologa, L. Siegel, and H. Londe. 1986. Theiler's virus in brain cell cultures: lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. J. Neurosci. Res. 15:491-501.
19. Graves, M. C., H. Londe, J. Merril, A. Verity, and R. Nishimura. 1984. Theiler's virus infection of cultured oligodendrocytes. Ann. Neurol. 16:151. (Abstract.)
20. Jarousse, N., L. Fiette, R. A. Grant, J. M. Hogle, A. McAllister, T. Michiels, C. Aubert, F. Tangy, M. Brahic, and C. P. Rossi. 1994. Chimeric Theiler's virus with altered tropism for the central nervous system. J. Virol. 68:2781-2786.
21. Jarousse, N., R. A. Grant, J. M. Hogle, L. Zhang, A. Senkowski, R. P. Roos, T. Michiels, M. Brahic, and A. McAllister. 1994. A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68:3364-3368.
22. Levy, M., C. Aubert, and M. Brahic. 1992. Theiler's virus replication in brain macrophages cultured in vitro. J. Virol. 66:3188-3193.
23. Lipton, H. L. 1975. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1147-1155.
24. Lipton, H. L., J. Kratochvil, P. Seth, and M. C. Dal Canto. 1984. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology 34:1117-1119.
25. Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-2533.
26. Liu, C., J. Collins, and E. Sharp. 1967. The pathogenesis of Theiler's GDVII encephalomyelitis virus infection in mice as studied by immunofluorescent technique and infecting titration. J. Immunol. 98:46-55.
27. Lorch, Y., A. Friedmann, H. L. Lipton, and M. Kotler. 1981. Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J. Virol. 40:560-567.
28. McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1990. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J. Virol. 64:4252-4257.
29. Miller, D. J., C. Rivera-Quinones, M. K. Njenga, J. L. Leibowitz, and M. Rodriguez. 1995. Spontaneous central nervous system remyelination in β2 microglobulin deficient mice following virus-induced demyelination. J. Neurosci. 15:8345-8352.
30. Njenga, M. K., K. D. Pavelko, J. Baisch, L. Xiaoqi, C. David, J. Leibowitz, and M. Rodriguez. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1729-1737.
31. Ohara, Y., H. Konno, Y. Iwasaki, T. Yamamoto, H. Terunuma, and H. Suzuki. 1990. Cytotropism of Theiler's murine encephalomyelitis viruses in oligodendrocyte-enriched cultures. Arch. Virol. 114:293-298.
32. Ohara, Y., S. Stern, J. Fu, L. Stillman, L. Klaman, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis virus. Virology 164:245-255.
33. Pullen, L. C., S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1993. Class I deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287-2293.
34. Rodriguez, M. 1985. Virus induced demyelination in mice: "dying back" of oligodendrocytes. Mayo Clin. Proc. 60:433-438.
35. Rodriguez, M., A. J. Dunkel, R. L. Thiemann, J. Leibowitz, M. Zijlstra, and R. Jaesnisch. 1993. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J. Immunol. 151:266-276.
36. Rodriguez, M., J. Leibowitz, and C. S. David. 1986. Susceptibility to Theiler's virus-induced demyelination: mapping of the gene within the H-2D region. J. Exp. Med. 163:620-631.
37. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:426-433.
38. Rodriguez, M., J. L. Leibowitz, H. C. Powell, and P. W. Lampert. 1983. Neonatal infection with the Daniel's strain of Theiler's murine encephalomyelitis virus. Lab. Invest. 49:672-678.
39. Rodriguez, M., E. Oleszak, and J. Leibowitz. 1987. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit. Rev. Immunol. 7:325-366.
40. Rodriguez, M., A. K. Patick, and L. R. Pease. 1990. Abrogation of resistance to Theiler's virus-induced demyelination in C57BL mice by total body irradiation. J. Neuroimmunol. 26:189-199.
41. Rodriguez, M., K. D. Pavelko, M. K. Njenga, W. C. Logan, and P. J. Wettstein. 1996. The balance between persistent virus infection and immune cells determines demyelination. J. Immunol. 157:5699-5709.
42. Rodriguez, M., and R. P. Roos. 1992. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/ DA viruses. J. Virol. 66:217-225.
43. Rodriguez, M., and S. Sriram. 1988. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-lyt-2 antibody. J. Immunol. 140:2950-2955.
44. Roos, R. P., S. Firestone, R. Wollmann, D. Variakojis, and B. G. W. Arnason. 1982. The effects of short term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2:223-234.
45. Roos, R. P., and R. Wollmann. 1984. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15:494-499.
46. Rosenthal, A., R. S. Fujinami, and P. W. Lampert. 1986. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab. Invest. 54:515-522.
47. Rossi, C. P., M. Delcroix, I. Huitinga, A. McAllister, N. van Rooijen, E. Claasen, and M. Brahic. 1997. Role of macrophages during Theiler's virus infection. J. Virol. 71:3336-3340.
48. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665-2672.
49. Simas, J. P., H. Dyson, and J. K. Fazakerley. 1995. The neurovirulent strain of Theiler's virus can replicate in glial cells. J. Virol. 69:5599-5606.
50. Tangy, F., M. McAllister, C. Aubert, and M. Brahic. 1991. Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J. Virol. 65:1616-1618.
51. Theiler, M. 1934. Spontaneous encephalitis of mice - a new virus disease. Science 80:122-123.
52. Wada, Y., M. L. Pierce, and R. S. Fujinami. 1994. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J. Virol. 68:1219-1223.
53. Weber, A., and M. Schachner. 1984. Maintenance of immunocytologically identified purkinje cells from mouse cerebellum in monolayer culture. Brain Res. 311:119-130.
54. Zurbriggen, A., M. Yamada, C. Thomas, and R. S. Fujinami. 1991. Restricted virus replication in the spinal cords of nude mice infected with Theiler's virus variants. J. Virol. 65:1023-1030.